Association of MDR1 gene polymorphism (G2677T) with chronic myeloid leukemia

Biology and Medicine

Volumn 2, Issue 4, 2010, Pages 17-21

  Sailaja, Kagita ^a   Surekha, Damineni ^a   Rao, Dunna Nageswara ^a   Raghunadharao, Digimarti ^b   Vishnupriya, Satti ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic myeloid leukemia; Drug response; Imatinib; MDR1 gene; Polymorphism

Indexed keywords

EID: 84861972149     PISSN: None     EISSN: 09748369     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB, 1987. Localization of the human multiple drug resistance gene mdr1 to 7q21.1. Human Genetics, 77: 142-144.
2. Capdeville R, Buchdunger E, Zimmermann J, Matter A, 2002. Glivec (STI571, Imatinib) - A rationally developed targeted anticancer drug. Nature Reviews Drug Discovery, 1: 493-502.
3. Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB, 1990. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. Journal of Biological Chemistry, 265: 506-514.
4. Drozdzik M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J, Sych Z, 2003. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics, 13: 259-263.
5. Druker BJ, Lee SJ, 2005. Chronic leukemias, In Devita VT, Hellman S, and Rosenberg SA (editors): Cancer, Principles and Practice of Oncology. Pubmed Lippincott, Philadelphia, 7th edition, p 2124.
6. Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, Molimard M, Krajinovic M, Mahon FX, 2008. Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood, 112(5): 2024-2027.
7. Gervasini G, Pharma D, Carrillo JA, Garcia M, Jose CS, Cabanillas A, Benitez J, 2006. Binding Cassette B1 (ABCB1) (Multidrug Resistance 1) G2677t/a Gene polymorphism is associated with high risk of lung cancer. Adenosine Triphosphate, 107(12): 2850-2856.
8. Goreva OB, Grishanova AY, Domnikova NP, Mukhin OV, Lyakhovich VV, 2004. MDR1 gene C1236T and C6+139T polymorphisms in the Russian population: associations with predisposition to lymphoproliferative diseases and drug resistance. Bulletin of Experimental Biology and Medicine, 138: 404-406.
9. Gottesman MM, Fojo T, Bates SE, 2002. Multidrug resistance in cancer: Role of ATP dependent transporter. Nature Reviews Cancer, 2: 48-58.
10. Gurney H, Wong M, Balleine RL, Rivory LP, McLachlan AJ, Hoskins JM, Wilcken N, Clarke CL, Mann GJ, Collins M, Delforce SE, Lynch K, Schran H, 2007. Imatinib deposition and ABCB1 (MDR1, Pglycoprotein) genotype. Clinical Pharmacology & Therapeutics, 82(1): 33-40.
11. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR, 2001. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clinical Pharmacology & Therapeutics, 70(2): 189-199.
12. Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K, 1989. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochemical and Biophysical Research Communications, 162: 224-231.
13. Komar AA, 2007. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics, 8: 1075-1080.
14. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A, Ohdo S, Ohtani H, Sawada Y, Higuchi S, Otsubo K, 2002. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clinical Pharmacology & Therapeutics, 72: 209-219.
15. Lahiri DK, Nurnberger J, 1991. A rapid nonenzymatic method for the preparation of HMW DNA from blood RFLP studies. Nucleic Acid Research, 19: 544.
16. Lamba J, Stoma S, Venkataramanan R, et al, 2006. MDR1 genotype is associated with hepatic cytochrome P4503A4 basal land induction phenotype. Clinical Pharmacology & Therapeutics, 79: 325-338.
17. Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y, 2003. Impact of drug transporter studies on drug discovery and development. Pharmacological Reviews, 55: 425-461.
18. Mochida Y, Taguchi K, Taniguchi S, Tsuneyoshi M, Hiroyuki Kuwano, Teruhisa Tsuzuki, Michihiko Kuwano, Morimasa Wada, 2003. The role of Pglycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis, 24: 1219-1224.
19. Potocink U, Ravnik-Glavac M, Glavac D, 2002. Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability. Cellular and Molecular Biology Letters, 7: 92-95.
20. Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I, 2002. The effects of the human MDR1 genotype on the expression of duodenal Pglycoprotein and disposition of the probe drug talinolol. Clinical Pharmacology & Therapeutics, 72 (5): 572-583.
21. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H, 2002. Association of the Pglycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. Journal of the American Society of Nephrology, 7: 1847-54.
22. Sun J, He ZG, Cheng G, Wang SJ, Hao XH, Zou MJ, 2004. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Medical Science Monitor, 10(1): 14.
23. Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, Takahashi M, Kurata Y, Kigawa J, Higuchi S, Terakawa N, Otsubo K, 2001. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. Journal of Pharmacology and Experimental Therapeutics, 297(3): 1137-1143.
24. Ueda K, Cornwell MM, Gottesman MM, et al, 1986. The mdr1 gene, responsible for multidrugresistance, codes for P-glycoprotein. Biochemical and Biophysical Research Communications, 141: 956-962.
25. Van Den MM, Heuvel-Eibrink EA, Weimer MJ, De Boevere B, Van Der Holt PJ, Vossebeld R, Pieters P, Sonneveld, 2001. MDR1 gene related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Blood, 97: 3605-3611